Publication | Open Access
An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma
392
Citations
29
References
2011
Year
Hematological MalignancyLymphoid NeoplasiaSingle-agent LenalidomideMedicineImmunologyOncologyRadiation OncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1